Literature DB >> 9651946

Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer.

T Valković1, K Lucin, M Krstulja, R Dobi-Babić, N Jonjić.   

Abstract

Monocyte chemotactic protein-1 (MCP-1) is a chemokine involved in the macrophage infiltration of tumor tissue. Tumor associated macrophages (TAMs) are a population of mononuclear-phagocytic cells, which can express complex functions related to tumor biology. The present study was designed to analyse the expression of MCP-1 in parenchymal and stromal elements on frozen sections of 27 breast invasive ductal carcinomas not otherwise specified (NOS) by immunohistochemistry. The expression of MCP-1 in tumor parenchyma and the degree of tumor differentiation were assessed. MCP-1 was detected in the parenchyma in 15 of 27 ductal carcinomas. Positive immunoreactivity manifested as diffuse, homogeneous, moderate or strong, cytoplasmic staining, confined to tumor epithelium. Generally, MCP-1-negative tumors tended to be well differentiated, while chemokine-positive tumors exhibited a low level of differentiation. MCP-1 immunoreactivity was also present in TAMs (CD68 positive cells) in 23 of 27 tumors, and in endothelial cells in 11 of 27 tumors. These results indicate that parenchymal and, more variably, stromal elements of human invasive ductal carcinomas NOS can express MCP-1 in vivo. Additionally, these findings suggest that MCP-1 expression in tumor parenchyma is correlated with the histological grade of ductal invasive breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651946     DOI: 10.1016/S0344-0338(98)80057-5

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  40 in total

1.  Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms.

Authors:  Stacey L Hembruff; Iman Jokar; Li Yang; Nikki Cheng
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model.

Authors:  Taryn L Cranford; Kandy T Velázquez; Reilly T Enos; Jackie E Bader; Meredith S Carson; Ioulia Chatzistamou; Mitzi Nagarkatti; E Angela Murphy
Journal:  Cancer Biol Ther       Date:  2017-01-11       Impact factor: 4.742

3.  Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.

Authors:  Hong Wang; Qiongwen Zhang; Hongyu Kong; Yunhui Zeng; Meiqin Hao; Ting Yu; Jing Peng; Zhao Xu; Jingquan Chen; Huashan Shi
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population.

Authors:  Vibha Singh; Priyanka Srivastava; Neena Srivastava; Rakesh Kapoor; Rama Devi Mittal
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

5.  Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells.

Authors:  Melanie Mestdagt; Myriam Polette; Giovanna Buttice; Agnes Noël; Atsuhisa Ueda; Jean-Michel Foidart; Christine Gilles
Journal:  Int J Cancer       Date:  2006-01-01       Impact factor: 7.396

6.  CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration.

Authors:  Robert D Loberg; Chi Ying; Matt Craig; Li Yan; Linda A Snyder; Kenneth J Pienta
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

Review 7.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

8.  Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model.

Authors:  Munehisa Takahashi; Hiroshi Miyazaki; Mutsuo Furihata; Hirofumi Sakai; Takeo Konakahara; Morihiro Watanabe; Tomoko Okada
Journal:  Clin Exp Metastasis       Date:  2009-07-24       Impact factor: 5.150

9.  Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.

Authors:  J L Steiner; J M Davis; J L McClellan; A Guglielmotti; E A Murphy
Journal:  Cytokine       Date:  2014-01-20       Impact factor: 3.861

10.  Human Vγ2Vδ2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors.

Authors:  Reeva Aggarwal; Jingwei Lu; Suman Kanji; Manjusri Das; Matthew Joseph; Maryam B Lustberg; Alo Ray; Vincent J Pompili; Charles L Shapiro; Hiranmoy Das
Journal:  Int J Cancer       Date:  2013-05-29       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.